Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | ACHE | P22303 | 7/20 | 0.38 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | NAAA | Q02083 | 1/20 | 0.32 |
| ▸ | CYP4F2 | P78329 | 3/20 | 0.31 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9287443 | 0.97 | ACHE (0.36) | ALDH1A1ACHECAMK2ATSHRCYP3A4 | |
| SCHEMBL2188513 | 0.94 | TSHR (0.42) | ALDH1A1ACHECAMK2ATSHRCYP3A4 | |
| SCHEMBL17368712 | 0.94 | ACHE (0.44) | ALDH1A1ACHETSHRCYP3A4GPR84 | |
| SCHEMBL575105 | 0.91 | ACHE (0.45) | ALDH1A1ACHECAMK2ATSHRCYP3A4 | |
| SCHEMBL575112 | 0.88 | ACHE (0.48) | ALDH1A1ACHETSHRCYP3A4GPR84 | |
| SCHEMBL9287648 | 0.88 | ACHE (0.35) | ALDH1A1ACHECAMK2ATSHRCYP3A4 | |
| SCHEMBL21143379 | 0.88 | ACHE (0.48) | ALDH1A1ACHETSHRCYP3A4GPR84 | |
| SCHEMBL21143358 | 0.88 | ACHE (0.48) | ALDH1A1ACHETSHRCYP3A4GPR84 | |
| SCHEMBL20437593 | 0.88 | ACHE (0.44) | ALDH1A1ACHECAMK2ATSHRCYP3A4 | |
| SCHEMBL3114601 | 0.88 | ACHE (0.48) | ALDH1A1ACHETSHRCYP3A4GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 291 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240238076-A1 | PROCESS FOR PRODUCING VASCULAR PROSTHESES | LUDWIG BOLTZMANN GESELLSCHAFT – ÖSTERREICHISCHE VEREINIGUNG ZUR FÖRDERUNG VON WISSENSCHAFTLICHEN FORSCHUNGEN (AT) | 2024-07-18 | — | — | US | claimed |
| EP-4284850-A1 | PROCESS FOR PRODUCING VASCULAR PROSTHESES | Medizinische Universität Wien (AT) | 2023-12-06 | — | — | EP | claimed |
| US-20230272148-A1 | THERMOPLASTIC POLY(URETHANE-UREA) POLYADDUCTS | TECHNISCHE UNIVERSITAET WIEN (AT) | 2023-08-31 | — | — | US | claimed |
| EP-3912969-B1 | METHOD FOR DIRECT CONVERSION OF CARBON DIOXIDE TO DIALKYL CARBONATES USING ETHYLENE OXIDE AS FEEDSTOCK | E3TEC SERVICE LLC (US) | 2022-11-30 | — | — | EP | claimed |
| WO-2022162166-A1 | PROCESS FOR PRODUCING VASCULAR PROSTHESES | MEDIZINISCHE UNIVERSITÄT WIEN (AT) | 2022-08-04 | — | — | WO | claimed |
| EP-4036136-A1 | METHOD FOR THE PREPARATION OF VASCULAR PROSTHESES | Medizinische Universität Wien (AT) | 2022-08-03 | — | — | EP | claimed |
| EP-3912969-A1 | METHOD FOR DIRECT CONVERSION OF CARBON DIOXIDE TO DIALKYL CARBONATES USING ETHYLENE OXIDE AS FEEDSTOCK | E3TEC Service, LLC (US) | 2021-11-24 | — | — | EP | claimed |
| CN-113597436-A | Electrochemical production of polymers | 何慧煌 | 2021-11-02 | — | — | CN | claimed |
| US-10941105-B1 | Method for direct conversion of carbon dioxide to dialkyl carbonates using ethylene oxide as feedstock | E3TEC SERVICE, LLC (US) | 2021-03-09 | — | — | US | claimed |
| CN-109431923-A | A kind of informer's pen core and preparation method thereof not faded persistently | 广州艾蓓生物科技有限公司 | 2019-03-08 | — | — | CN | claimed |
| US-20150105357-A1 | Lactate-Based Fulvestrant or Fulvestrant Derivative Oily Preparation and Preparation Method Thereof | XI'AN LIBANG PHARMACEUTICAL CO., LTD (CN) | 2015-04-16 | — | — | US | claimed |
| EP-2832349-A1 | LACTATE-BASED FULVESTRANT OR FULVESTRANT DERIVATIVE OILY PREPARATION AND PREPARATION METHOD THEREOF | Lipont Pharmaceuticals Inc. (CA) | 2015-02-04 | — | — | EP | claimed |
| CN-103515629-A | Composite ultrafiltration or nanofiltration membrane for hydrogen-chlorine fuel cells, and preparation and application thereof | DALIAN CHEMICAL PHYSICS INST | 2014-01-15 | — | — | CN | claimed |
| CN-103296296-A | Porous membrane for hydrogen-chloride fuel battery, as well as preparation method and application of porous membrane | DALIAN CHEMICAL PHYSICS INST | 2013-09-11 | — | — | CN | claimed |
| CN-1888878-B | Non-combustible dye check cleaning liquid and preparation method thereof | HUDONG ZHONGHUA SHIPBUILDING | 2012-05-30 | — | — | CN | claimed |
| US-20080038316-A1 | Conveniently implantable sustained release drug compositions | RAMSCOR, INC. | 2008-02-14 | — | — | US | claimed |
| CN-1888876-A | Non-combustion dye check penetrating fluid and preparing method thereof | HUDONG ZHONGHUA SHIPBUILDING (CN) | 2007-01-03 | — | — | CN | claimed |
| CN-1888873-A | Reactive dye check cleaning liquid and producing method thereof | HUDONG ZHONGHUA SHIPBUILDING (CN) | 2007-01-03 | — | — | CN | claimed |
| CN-1888878-A | Non-combustion dye check cleaning liquid and preparing method thereof | HUDONG ZHONGHUA SHIPBUILDING (CN) | 2007-01-03 | — | — | CN | claimed |
| US-4085533-A | IMMISCIBLE LIQUIDS | EWALD ALFRED | 1978-04-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150105357-A1 | Lactate-Based Fulvestrant or Fulvestrant Derivative Oily Preparation and Preparation Method Thereof | LDHA, LDHB, SHBG | ALDH1A1 383/4885ACHE 2273/4885CAMK2A 650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.